arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Encompass Health Corp

EHC
$125.28 ▲ +0.69 (+0.55%) at close
Healthcare ·Services-Hospitals ·USServices-Hospitals
71 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
76
Health
Good
Bullish
auto_awesome

Analytical Summary

Encompass Health Corp shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $12.4B
Dividend Yield 0.15%
Revenue Growth 9.0%
Op. Margin
ROIC
FCF / Share None
Trailing P/E 63.9x
Price / Book 4.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.59B
↑ +9.0%
Net Income Profit after all expenses
$194.50M
↑ +28.4%
FCF / Share Free cash flow per share
$0.90
↓ -31.9%
Long-Term Debt Long-term obligations
$1.22B
↓ -2.2%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
64
Returns
89

Dividend History

Dividend / share · sourced from SEC filings
$0.17 Latest / share
+13.3% YoY
-1.9% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters